+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares), By End Use (Hospital, Emergency Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecast, 2025 - 2030

  • PDF Icon

    Report

  • 154 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 5263845
The global neurothrombectomy devices market size is expected to reach USD 1.1 billion by 2030, registering a CAGR of 6.94% from 2025 to 2030. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights

  • Based on products, clot retrievers segment dominated the market in 2024, with a share of 57.8% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players.
  • Based on end-use, hospital segment dominated the market in 2024 with a share of 70.4% due to improving health care facilities and the availability of advanced equipment in the hospitals.
  • Europe led the market with the maximum revenue share of 32.9% in 2024, owing to the increasing number of patients suffering from acute ischemic stroke in this region.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Neurothrombectomy Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Neurothrombectomy Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of suppliers
3.4.1.2. Bargaining power of buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Neurothrombectomy Devices Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Clot Retrievers
4.3.1. Clot Retrievers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Aspiration/Suction Devices
4.4.1. Aspiration/Suction Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Vascular Snares
4.5.1. Vascular Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Neurothrombectomy Devices Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Neurothrombectomy Devices Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
5.3. Hospitals
5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Emergency Clinics
5.4.1. Emergency Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Ambulatory Surgical Centers
5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis
6.1. Neurothrombectomy Devices Market Share, By Region, 2024 & 2030 (USD Million)
6.2. North America
6.2.1. North America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Regulatory Landscape/Reimbursement Structure
6.2.2.3. Competitive Scenario
6.2.2.4. U.S. Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Regulatory Landscape/Reimbursement Structure
6.2.3.3. Competitive Scenario
6.2.3.4. Canada Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Key Country Dynamics
6.2.4.2. Regulatory Landscape/Reimbursement Structure
6.2.4.3. Competitive Scenario
6.2.4.4. Mexico Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Regulatory Landscape/Reimbursement Structure
6.3.2.3. Competitive Scenario
6.3.2.4. UK Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Regulatory Landscape/Reimbursement Structure
6.3.3.3. Competitive Scenario
6.3.3.4. Germany Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Regulatory Landscape/Reimbursement Structure
6.3.4.3. Competitive Scenario
6.3.4.4. France Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Regulatory Landscape/Reimbursement Structure
6.3.5.3. Competitive Scenario
6.3.5.4. Italy Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Regulatory Landscape/Reimbursement Structure
6.3.6.3. Competitive Scenario
6.3.6.4. Spain Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Regulatory Landscape/Reimbursement Structure
6.3.7.3. Competitive Scenario
6.3.7.4. Denmark Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Regulatory Landscape/Reimbursement Structure
6.3.8.3. Competitive Scenario
6.3.8.4. Sweden Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Regulatory Landscape/Reimbursement Structure
6.3.9.3. Competitive Scenario
6.3.9.4. Norway Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Landscape/Reimbursement Structure
6.4.2.3. Competitive Scenario
6.4.2.4. Japan Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Landscape/Reimbursement Structure
6.4.3.3. Competitive Scenario
6.4.3.4. China Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Landscape/Reimbursement Structure
6.4.4.3. Competitive Scenario
6.4.4.4. India Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Regulatory Landscape/Reimbursement Structure
6.4.5.3. Competitive Scenario
6.4.5.4. Australia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Regulatory Landscape/Reimbursement Structure
6.4.6.3. Competitive Scenario
6.4.6.4. Thailand Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Regulatory Landscape/Reimbursement Structure
6.4.7.3. Competitive Scenario
6.4.7.4. South Korea Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Landscape/Reimbursement Structure
6.5.2.3. Competitive Scenario
6.5.2.4. Brazil Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Landscape/Reimbursement Structure
6.5.3.3. Competitive Scenario
6.5.3.4. Argentina Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Landscape/Reimbursement Structure
6.6.2.3. Competitive Scenario
6.6.2.4. South Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Landscape/Reimbursement Structure
6.6.3.3. Competitive Scenario
6.6.3.4. Saudi Arabia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Landscape/Reimbursement Structure
6.6.4.3. Competitive Scenario
6.6.4.4. UAE Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Landscape/Reimbursement Structure
6.6.5.3. Competitive Scenario
6.6.5.4. Kuwait Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Medtronic
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Stryker
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Acandis GmbH
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Phenox GmbH
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Penumbra
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Vesalio, LLC.
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Terumo Corporation
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. MIVI Neuroscience, Inc.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Rapid Medical
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. Infinity Neuro
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
Table 4 North America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 5 North America neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 6 U.S neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 7 U.S neurothrombectomy devices, by end use, 2018 - 2030 (USD Million)
Table 8 Canada neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 9 Canada neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 10 Mexico neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 11 Mexico neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 12 Europe neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
Table 13 Europe neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 14 Europe neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 15 UK neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 16 UK neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 17 Germany neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 18 Germany neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 19 France neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 20 France neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 21 Italy neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 22 Italy neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 23 Spain neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 24 Spain neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 25 Denmark neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 26 Denmark neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 27 Sweden neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 28 Sweden neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 29 Norway neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 30 Norway neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 31 Asia Pacific neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
Table 32 Asia Pacific neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 33 Asia Pacific neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 34 China neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 35 China neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 36 Japan neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 37 Japan neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 38 India neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 39 India neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 40 Australia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 41 Australia neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 42 South Korea neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 43 South Korea neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 44 Thailand neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 45 Thailand neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 46 Latin America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
Table 47 Latin America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 48 Latin America neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 49 Brazil neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 50 Brazil neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 51 Argentina neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 52 Argentina neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 53 Middle East & Africa neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
Table 54 Middle East & Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 56 South Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 57 South Africa neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 60 UAE neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 61 UAE neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
Table 62 Kuwait neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 63 Kuwait neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Neurothrombectomy device market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2024)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Neurothrombectomy device market: Product movement analysis
Fig. 19 Segment dashboard
Fig. 20 Neurothrombectomy device market product outlook: Key takeaways
Fig. 21 Clot retrievers market, 2018 - 2030 (USD Million)
Fig. 22 Aspiration/ suction devices market, 2018 - 2030 (USD Million)
Fig. 23 Vascular snares market, 2018 - 2030 (USD Million)
Fig. 24 Neurothrombectomy device market: End Use movement analysis
Fig. 25 Segment dashboard
Fig. 26 Neurothrombectomy device market end use outlook: Key takeaways
Fig. 27 Hospital market, 2018 - 2030 (USD Million)
Fig. 28 Emergency clinics market, 2018 -- 2030 (USD Million)
Fig. 29 Ambulatory Surgical Centers market, 2018 - 2030 (USD Million)
Fig. 30 Regional outlook, 2024 & 2030
Fig. 31 Regional market dashboard
Fig. 32 Regional market place: Key takeaways
Fig. 33 North America neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 34 US neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 35 Canada neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 36 Europe neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 37 UK neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 38 Germany neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 39 France neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 40 Italy neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 41 Spain neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 43 Japan neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 44 China neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 45 India neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 46 South Korea neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 47 Australia neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 48 Latin America neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 49 Brazil neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 50 Mexico neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 51 MEA neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 52 South Africa neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 54 UAE neurothrombectomy devices market, 2018 - 2030 (USD Million)
Fig. 55 Company market share analysis, 2024

Companies Mentioned

  • Medtronic
  • Stryker Corporation
  • Acandis GmbH
  • Phenox GmbH
  • Penumbra Inc.
  • Vesalio

Methodology

Loading
LOADING...

Table Information